Published

Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Frontiers in pharmacology
Date: 2021-01-01
Source: PubMed
DOI: 10.3389/fphar.2021.788155
PubMed: 35431912

Authors

Murphy R Kettner H Zeifman R Giribaldi B Kartner L Martell J Read T Murphy-Beiner A Baker-Jones M Nutt D Erritzoe D Watts R Carhart-Harris R

Watch author

Derived topics and classifications

psilocybin Depression Emotional Processing Mystical Experience Randomized Controlled Trial Randomized Controlled Trial

Citation graph

0 referenced DOIs found in stored source metadata. 8 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis2026-08-01 Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overview2026-07-13 Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations2026-06-01 Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression2026-06-01 Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression2026-04-09 Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis2026-04-01 The Psychological Support Model in Psilocybin Research: Psychotherapy in Disguise?2026-03-01 Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.2021-01-01

Related papers

TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance TherapyClinicalTrials.gov · 2026-08-12 TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer SurvivorsClinicalTrials.gov · 2026-08-12 Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot StudyClinicalTrials.gov · 2026-08-10 PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site, Open-label, Single Arm Phase I/II Proof-of-concept, Dose-finding, and Feasibility Clinical TrialClinicalTrials.gov · 2026-07-10 A Pilot Mechanistic RCT of Psilocybin With Mindfulness-based Therapy vs Support for Posttraumatic Stress Disorder (PTSD)ClinicalTrials.gov · 2026-06-25 Does Psilocybin Require Psychedelic Effects to Treat Depression? A 4-Week, Double-Blind, Proof-of-Concept Randomized Controlled TrialClinicalTrials.gov · 2026-05-07 Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use DisorderClinicalTrials.gov · 2026-03-30 A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in VeteransClinicalTrials.gov · 2026-08-14